Sponsor:
Genentech, Inc.
Code:
NCT05968326
Conditions
Adenocarcinoma, Pancreatic Ductal
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Autogene cevumeran
Atezolizumab
mFOLFIRINOX
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations